| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |